HER2 activates RAS by interacting with Grb2 and SOS [123]; however, the predominant downstream signaling pathway may vary based on tumor type, with prevalent activation of PI3K over ERK pathway in breast cancer [124,125]. The gene discussed is PIK3CA; the disease is breast cancer.